Sensitivity and reproducibility in adenoviral infectious titer determination

Nature Medicine

Volumn 3, Issue 7, 1997, Pages 808-811

  Nyberg Hoffman, Cassandra ^a,b   Shabram, Paul ^c   Li, Wei ^a,b   Giroux, Daniel ^c   Aguilar Cordova, Estuardo ^a,b,d  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b TEXAS CHILDREN S CANCER CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRION; VIRUS DETECTION; VIRUS INFECTION;

EID: 0030855528     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0797-808     Document Type: Short Survey

References (24)

1. Maizel, J.V., White, D.O. & Scharff, M.D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36, 115-125 (1968).
2. Horwitz, M.S. in Virology (eds. Fields, B.N. et al.) Vol. 2, 1679-1721 (Raven, New York, 1990).
3. Schneider, M.D. & French, B.A. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 88, 1937-1941 (1993).
4. Goodman, J.C. et al. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic and molecular studies. Hum. Gene Ther. 7, 1241-1250 (1996).
5. Crystal, R.G. et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51 (1994).
6. Durham, H.D. et al. Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue. Exp. Neurol. 140, 14-20 (1996).
7. Toloza, E.M. et al. In vivo cancer gene therapy with a recombinant Interleukin-2 adenovirus vector. Cancer Gene Ther. 3, 11-17 (1996).
8. Schulick, A.H., Newman, K.D., Virmani, R. & Dichek, D.A. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 91, 2407-2414 (1995).
9. Simon, R.H. et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780 (1993).
10. Chuck, A.S., Clarke, M.F. & Palsson, B.O. Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 6, 1527-1534 (1996).
11. Allison, A.C. & Valentine, R.C. Virus particle adsorption. III. Adsorption of viruses by cell monolayers and effects of some variables on adsorption. Biochim. Biophys. Acta 40, 400-410 (1959).
12. Strayer, D.S. et al. Titer replication-defective virus for use in gene transfer. BioTechniques 22, 447-450 (1997).
13. Mittereder, N., March, K.L. & Trapnell, B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509 (1996).
14. Trapnell, B.C. Considerations for the determination of adenovirus vector particle concentration and infectivity. Natcher Conf. Center Proc. 1, 59 (1996).
15. Van Holde, K.E. Physical Biochemistry (Prentice-Hall, Englewood Cliffs, New Jersey, 1971).
16. Huyghe, B.G. et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther. 6, 1403-1416 (1995).
17. Kotani, H. et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28 (1994).
18. Oliver, C.J., Shortridge, K.F. & Belyavin, C. Diffusion coefficient and molecular weight of type 5 adenovirus by photon-correlation spectroscopy. Biochim. Biophys. Acta 437, 589-598 (1976).
19. Marshall, A.G. Biophysical Chemistry, Principles, Techniques and Applications (John Wiley, New York, 1975).
20. Winters, W.D. & Russell, W.C. Studies on the assembly of adenovirus in vitro. J. Gen. Virol. 10, 181-194 (1971).
21. McAllister, R.M., Goodheart, C.R., Mirabal, V.Q. & Huebner, R.J. Human adenoviruses: Tumor production in hamsters by types 12 and 18 grown from single plaques. PSEBM 122, 455-458 (1966).
22. Graham, F.L. & Prevec, L. in Methods in Molecular Biology (ed. Murray, E.J.) 109-128 (Humana Press, Clifton, New Jersey, 1991).
23. Kochanek, S. et al. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731-5736 (1996).
24. Green, M. & Pina, M. Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology 20, 199-207 (1963).